Doximity (DOCS) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Doximity (DOCS) do?
Doximity Inc (DOCS) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Sells digital marketing subscriptions to pharmaceutical manufacturers and health systems seeking to reach medical professionals. Operates a verified digital network used by over eighty percent of all United States physicians. It is worth $5.28B on the market and sold $661.36M over the last year.
- Market cap
- $5.28B
- P/E ratio
- 41.2×
- Annual sales
- $661.36M
- Sector
- Healthcare
- Industry
- Health Information Services
- Brief updated
- Nov 12, 2026
Brands and businesses behind DOCS
- Amion: Sells physician scheduling software that helps hospitals and clinics organize shifts and on-call rotations.
- Curative: Places doctors and advanced practice clinicians into temporary and permanent medical staff roles across healthcare systems.
DOCS’s flags, in plain English
Each flag is a number from Doximity’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 12, 2026.
Stupid Cash
Can pay this year's bills 6.3 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Low debt
Low debt, only 1% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Wide Gross Margin
Gross margin of 85.6% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Priced for Perfection
Priced at 41.2 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about DOCS
How big is Doximity?
Doximity’s market cap is $5.28B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $661.36M: what customers paid the company over the last year, before any costs.
What is DOCS’s P/E ratio?
DOCS’s P/E ratio is 41.2×. Investors pay about 41.2 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with DOCS?
Pharmaceutical advertising accounts for the vast majority of annual sales, which concentrates revenue in drug commercialization budgets. That is one risk on Doximity’s card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Doximity’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. DOCS’s filings on SEC.gov. The Margin Monkey is research, not advice.
